ScreenerHero

GXE Lakefront Biotherapeutics NV

XETRA · DE · Healthcare · Biotechnology · lakefrontbio.com
26.40EUR+2.48%Mkt Cap: 1.88B $P/E: 2.93

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a ph…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap1.88B USD
Enterprise Value-589.03M USD
Revenue (TTM)1.08B USD
Gross Profit1.18B USD
Net Income (TTM)348.79M USD
Revenue/Share15.03 EUR
Last Price26.40 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees196
CountryDE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)2.93
P/E (Forward)—
PEG—
EV/EBITDA-0.95
EV/Revenue-0.55
P/S1.70
P/B0.52
EPS (TTM)9.02
EPS (Forward)—
52W Range
22.8416% of range44.47
52W High44.47 EUR
52W Low22.84 EUR
Profitability
Gross Margin97.33%
Oper. Margin-359.30%
EBITDA Margin57.43%
Profit Margin28.85%
ROE9.92%
ROA9.42%
Growth
Revenue Growth-81.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-279.84M USD
CapEx (TTM)15.06M USD
FCF Margin13.95%
FCF Yield7.99%
Net Debt-2.43B USD
Net Debt/EBITDA-3.93
Balance Sheet
Debt/Equity0.00
Current Ratio32.84
Quick Ratio32.65
Book Value/Sh49.71 EUR
Cash/Share34.11 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.65.48M
Float23.72M
Insiders25.36%
Institutions43.15%
Technical
SMA 5024.58 (+7.4%)
SMA 20025.89 (+2.0%)
Beta0.12
S&P 52W Chg14.58%
Avg Vol (30d)499
Avg Vol (10d)865
Technical Indicators
RSI (14)59.0
MACD0.4705
MACD Signal0.4229
MACD Hist.+0.0477
BB Upper27.86 EUR
BB Middle25.20 EUR
BB Lower22.55 EUR
BB Width21.08%
ATR (14)0.5890 EUR
Vol Ratio (20d)0.50x